Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Ducassou

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|June 4, 2017
[Adolescents and young adults with acute lymphoblastic leukemia. A specific management]Nicolas Boissel, Stéphane Ducassou
Pediatric Blood & Cancer|April 20, 2016
Neonatal Solid Tumors: Incidence and Survival in FranceEmmanuel Desandes, Sandra Guissou, Stéphane Ducassou, et al.
La Revue Du Praticien|February 3, 2015
[Long term follow-up after chilhood cancer]Dominique Plantaz, Marie-Dominique Tabone, Claire Berger, et al.
Neuroradiology|April 24, 2019
Correction to: Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in childrenPierre Marsault, Stéphane Ducassou, Fanny Menut, et al.
Pediatric Blood & Cancer|August 8, 2015
Treatment of Childhood T-Cell Lymphoblastic Lymphoma-Long-Term Results of the SFOP LMT96 TrialChristophe Bergeron, Carole Coze, Céline Segura, et al.
The Pediatric Infectious Disease Journal|August 8, 2015
Invasive Fungal Infections in Pediatric Acute Myelogenous LeukemiaStéphane Ducassou, Delphine Rivaud, Anne Auvrignon, et al.
Expert Review of Anticancer Therapy|July 1, 2008
Medulloblastoma: what is the role of molecular genetics?Natacha Entz-Werle, Emilie De Carli, Stéphane Ducassou, et al.
Pediatric Blood & Cancer|January 15, 2019
Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomasMarie Dilly-Feldis, Nathalie Aladjidi, John K Refait, et al.
Neuroradiology|March 25, 2019
Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in childrenPierre Marsault, Stéphane Ducassou, Fanny Menut, et al.
Mycoses|July 6, 2024
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?Rémy Gerard, Frédéric Gabriel, Isabelle Accoceberry, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|June 4, 2017
[Adolescents and young adults with acute lymphoblastic leukemia. A specific management]Nicolas Boissel, Stéphane Ducassou
Pediatric Blood & Cancer|April 20, 2016
Neonatal Solid Tumors: Incidence and Survival in FranceEmmanuel Desandes, Sandra Guissou, Stéphane Ducassou, et al.
La Revue Du Praticien|February 3, 2015
[Long term follow-up after chilhood cancer]Dominique Plantaz, Marie-Dominique Tabone, Claire Berger, et al.
Neuroradiology|April 24, 2019
Correction to: Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in childrenPierre Marsault, Stéphane Ducassou, Fanny Menut, et al.
Pediatric Blood & Cancer|August 8, 2015
Treatment of Childhood T-Cell Lymphoblastic Lymphoma-Long-Term Results of the SFOP LMT96 TrialChristophe Bergeron, Carole Coze, Céline Segura, et al.
The Pediatric Infectious Disease Journal|August 8, 2015
Invasive Fungal Infections in Pediatric Acute Myelogenous LeukemiaStéphane Ducassou, Delphine Rivaud, Anne Auvrignon, et al.
Expert Review of Anticancer Therapy|July 1, 2008
Medulloblastoma: what is the role of molecular genetics?Natacha Entz-Werle, Emilie De Carli, Stéphane Ducassou, et al.
Pediatric Blood & Cancer|January 15, 2019
Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomasMarie Dilly-Feldis, Nathalie Aladjidi, John K Refait, et al.
Neuroradiology|March 25, 2019
Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in childrenPierre Marsault, Stéphane Ducassou, Fanny Menut, et al.
Mycoses|July 6, 2024
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?Rémy Gerard, Frédéric Gabriel, Isabelle Accoceberry, et al.
Pageof 8